One of the most lethal forms of breast cancer has long shrugged off the best drugs in the oncologist’s arsenal, leaving ...
Scientists are reprogramming the immune system through cutting-edge approaches like CAR-T cells, engineered dendritic vaccines, AI-driven antibody design, and senolytic therapies, highlighting both ...
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on ...
Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc.
This fall, tens of thousands of high-school seniors in Tennessee will receive letters stating that they’ve got a guaranteed seat at dozens of in-state colleges — no need to complete a traditional ...
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. In this manuscript, Rainey et al investigated the effects of ...
Scientists from Nagoya University have developed a fast and safe method to create lung cells from skin-like fibroblasts – without using stem cells. This technique could allow for new regenerative ...
The researchers' success in direct reprogramming of mouse fibroblasts into alveolar epithelial-like cells may lead to new treatments for serious lung diseases. Researchers in Japan have successfully ...
Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells ...